Lingjie Ke
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 3
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems 3
-
- Nanoplatforms for cancer theranostics 6
-
- RNA Interference and Gene Delivery 4
-
- Ocular Surface and Contact Lens 4
-
- CAR-T cell therapy research 3
-
- Virus-based gene therapy research 2
-
- Wound Healing and Treatments 2
Lingjie Ke
18 papers receiving 424 citations
Peers
Comparison fields: 5 of 73
- Biomaterials 137
- Pharmaceutical Science 47
- Biomedical Engineering 191
- Molecular Medicine 21
- Surfaces, Coatings and Films 25
Countries citing papers authored by Lingjie Ke
This map shows the geographic impact of Lingjie Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjie Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjie Ke more than expected).
Fields of papers citing papers by Lingjie Ke
This network shows the impact of papers produced by Lingjie Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjie Ke. The network helps show where Lingjie Ke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lingjie Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 40 | |
| 3 | 2023 | 16 | |
| 4 | 2022 | 18 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 43 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 22 | |
| 9 | 2021 | 21 | |
| 10 | 2021 | 25 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 17 | |
| 13 | 2021 | 30 | |
| 14 | 2021 | 87 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 3 | |
| 17 | 2020 | 34 | |
| 18 | 2020 | 0 | |
| 19 | 2019 | 36 |
About Lingjie Ke
Lingjie Ke is a scholar working on Pharmaceutical Science, Biomaterials and Rehabilitation, having authored 19 papers that have together received 431 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (6 papers), RNA Interference and Gene Delivery (4 papers), Ocular Surface and Contact Lens (4 papers), CAR-T cell therapy research (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Advanced Drug Delivery Systems (3 papers), Virus-based gene therapy research (2 papers) and Wound Healing and Treatments (2 papers). The work is most often cited by research in Biomaterials (137 citations), Pharmaceutical Science (47 citations) and Biomedical Engineering (191 citations). Lingjie Ke has collaborated with scholars based in China and Singapore. Frequent co-authors include Yun‐Long Wu, Zibiao Li, Zhiguo Li, Xian Jun Loh, Hongwei Cheng, Caisheng Wu, Xiaoshan Fan, Xiaodong Chen, Pingqiang Cai and Gang Liu. Their work appears in journals such as Advanced Materials, Nature Communications and Chemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.